paclitaxel has been researched along with Wet Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, HT; Evers, C; Gross, N; Hansen, LL; Hua, J; Martin, G; Michaelis, U; Ranjbar, M; Schulze, B | 1 |
1 other study(ies) available for paclitaxel and Wet Macular Degeneration
| Article | Year |
|---|---|
Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Disease Models, Animal; Drug Delivery Systems; Humans; Liposomes; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prodrugs; Vascular Endothelial Growth Factor A; Verteporfin; Wet Macular Degeneration | 2013 |